Showing results (11-20 of 44) with videos related to
Sort By:
Pageof 5
Echocardiography (Mount Kisco, N.Y.)|February 15, 2001
Esophageal Perforation After Transesophageal EchocardiogramMichael Y. Shapira, Boaz Hirshberg, Ronit Agid, et al.Clinical Pharmacology and Therapeutics|April 15, 2022
The Impact of CYP2C9*11 Allelic Variant on the Pharmacokinetics of Phenytoin and (S)-WarfarinMaor Wanounou, Chanan Shaul, Zahi Abu Ghosh, et al.Clinical Pharmacokinetics|June 14, 2022
Phenytoin Metabolic Ratio, a Marker of CYP2C9 Activity, is Superior to the CYP2C9 Genotype as a Predictor of (S)-Warfarin ClearanceChanan Shaul, Simcha Blotnick, Liat Adar, et al.Pharmacogenetics and Genomics|May 17, 2018
The hemodynamic response to constant dobutamine infusion: the effect of ADRB1 389 polymorphism and sexDotan Yogev, Maamoun Basheer, Amichai Perlman, et al.Clinical Therapeutics|March 16, 2012
Effects of CYP4F2 polymorphism on response to warfarin during induction phase: a prospective, open-label, observational cohort studyIdit Bejarano-Achache, Liran Levy, Liat Mlynarsky, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 5, 2024
A phase I study assessing the safety and tolerability of SPL84, an inhaled antisense oligonucleotide for treatment of cystic fibrosis patients with the 3849 +10kb C->TYoseph Caraco, Maor Wanounou, Simcha Blotnick, et al.Journal of the American Geriatrics Society|December 13, 2016
Long-Term Outcomes of Medication Intervention Using the Screening Tool of Older Persons Potentially Inappropriate Prescriptions Screening Tool to Alert Doctors to Right Treatment CriteriaDvora Frankenthal, Avi Israeli, Yoseph Caraco, et al.Epidemiologia (Basel, Switzerland)|August 22, 2023
Real-World Utilization of Molnupiravir during the COVID-19 Omicron Surge in IsraelClara Weil, Tobias Bergroth, Anna Eisenberg, et al.Clinical Therapeutics|March 9, 2010
Effects of folic acid supplementation on the pharmacokinetics and anticoagulant effect of warfarin: an open-label, prospective study of long-term administration in adultsMordechai Muszkat, Omer Bialer, Simcha Blotnick, et al.Frontiers in Neurology|November 28, 2022
The pharmacokinetics of continuous subcutaneous levodopa/carbidopa infusion: Findings from the ND0612 clinical development programPeter A LeWitt, Fabrizio Stocchi, David Arkadir, et al.Pageof 5